EcoDrugPlus

Ensembl ID : YLR318W
Description: -
43 Possible Orthologues:

Title

Ensembl ID : YLR325C
Description: -
67 Possible Orthologues:

Title

Ensembl ID : YLR333C
Description: -
88 Possible Orthologues:

Title

Ensembl ID : YLR340W
Description: -
101 Possible Orthologues:

Title

Ensembl ID : YLR344W
Description: -
113 Possible Orthologues:

Title

Ensembl ID : YLR367W
Description: -
104 Possible Orthologues:

Title

Ensembl ID : YLR388W
Description: -
67 Possible Orthologues:

Title

Ensembl ID : YLR406C
Description: -
96 Possible Orthologues:

Title

Ensembl ID : YLR421C
Description: -
66 Possible Orthologues:

Title

Ensembl ID : YLR448W
Description: -
82 Possible Orthologues:

Title

Ensembl ID : YLR450W
Description: -
119 Possible Orthologues:

Title

Ensembl ID : YLR460C
Description: -
920 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).